评估基于体重的CT协议修改对降低CT引导肝肾脏肿瘤射频消融辐射剂量的效果
该回顾性研究评估了CT引导经皮肝肾脏肿瘤射频消融的辐射剂量,并分析基于体重调整CT协议(管电压和管电流)对降低总体剂量的作用。结果显示,协议修改后平均CTDI从16.5±2.3 mGy降至6.63±0.67 mGy,总体降低59.6%;肝脏消融降低65.96%(p<0.0001),肾脏消融降低38.97%(p=0.0153),且未显著牺牲图像质量。
要点
- 基于体重的CT协议修改可使肝肾脏射频消融的CTDI从16.5±2.3 mGy降至6.63±0.67 mGy,总体降低59.6%。
- 肝脏消融的剂量降低幅度为65.96%(p<0.0001),肾脏消融为38.97%(p=0.0153)。
- 图像质量、针定位、病灶可见性及操作者信心评分均保持在较高水平(3-5分)。
核心结论
- 简单的基于体重的CT协议修改可显著降低肝肾脏经皮消融的辐射剂量,且未显著牺牲图像质量。
研究设计与样本
- 回顾性研究,先回顾2009年1月1日至2009年12月31日期间的CT引导肝肾脏射频消融病例(90例男性,48例女性;年龄42-81岁),随后对后续病例应用基于体重的管电压和管电流协议修改(18例男性,11例女性;年龄48-82岁)。
诊断标准与关键数值
- 协议修改后平均CTDI从16.5±2.3 mGy降至6.63±0.67 mGy,总体降低59.6%;肝脏消融降低65.96%(p<0.0001),肾脏消融降低38.97%(p=0.0153)。图像质量评分3-5分,针定位4-5分,病灶可见性3-5分,操作者信心4-5分。体重超过180磅(82 kg)的患者剂量降低更明显(p<0.0001)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study assessed radiation dose after CT-guided percutaneous radiofrequency ablations (RFAs) of hepatic and renal tumors and the effect of weight-based CT protocol modification for lowering overall dose in these procedures.
MATERIALS AND METHODS: CT-guided RFA for renal and hepatic ablations performed from January 1, 2009, through December 31, 2009, were retrospectively reviewed (90 men and 48 women; age, 42-81 years). The radiation dose was recorded during each of the following steps: planning, performing, and postprocedure. Weight-based protocol modification changes in tube voltage and tube current were then applied to renal and hepatic ablations performed subsequently (18 men and 11 women; age, 48-82 years). Image quality, needle localization, lesion detection, ability to detect complications, and overall operator satisfaction were noted for each case (score, 1-5). Dose reduction after modification was then calculated.
RESULTS: Retrospective analysis found a mean (± SD) overall CT dose index (CTDI) for CT-guided RFA to be 16.5 ± 2.3 mGy. After protocol modification, the mean CTDI decreased to 6.63 ± 0.67 mGy, a 59.6% reduction overall; for hepatic ablations, the reduction was 65.96% (p < 0.0001) and the reduction for renal ablations was 38.97% (p = 0.0153). Image quality analysis showed high operator satisfaction (3-5), including adequate needle localization (4-5), lesion visibility (3-5), and high performer confidence (4-5). Higher dose reduction was noted for patients weighing more than 180 lb (82 kg) (p < 0.0001).
CONCLUSION: Simple weight-based CT protocol modifications can significantly reduce radiation dose during CT-guided percutaneous ablations in the liver and kidneys without significantly sacrificing image quality.
引用
- Gupta S, Arellano RS, Gervais DA, et al. Assessing the Effect of Weight-Based Protocol Modifications to Lower Dose for CT-Guided Hepatic and Renal Tumor Radiofrequency Ablations. AJR Am J Roentgenol. 2018. PMID: 29323550. doi:10.2214/AJR.17.17952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。